Precipio, Inc. (NASDAQ:PRPO – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $6.21 and traded as low as $5.11. Precipio shares last traded at $5.15, with a volume of 2,714 shares.
Precipio Trading Down 3.2 %
The firm has a fifty day moving average of $5.96 and a 200-day moving average of $6.21. The company has a debt-to-equity ratio of 0.01, a quick ratio of 0.62 and a current ratio of 0.78. The stock has a market capitalization of $7.57 million, a price-to-earnings ratio of -1.51 and a beta of 1.27.
Precipio (NASDAQ:PRPO – Get Free Report) last issued its earnings results on Tuesday, May 14th. The biotechnology company reported ($1.46) earnings per share for the quarter. The company had revenue of $3.43 million during the quarter. Precipio had a negative return on equity of 46.12% and a negative net margin of 31.00%.
About Precipio
Precipio, Inc, a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels.
Featured Stories
- Five stocks we like better than Precipio
- Are Penny Stocks a Good Fit for Your Portfolio?
- Darden Stock Up After Q4 Earnings Beat, Cautious FY25 Outlook
- What Are Growth Stocks and Investing in Them
- Celsius Stock: Why Piper Sandler Forecasts a 50% Surge
- Investing in Commodities: What Are They? How to Invest in Them
- Accenture’s Stock Earnings Reveal an AI-Powered Growth Strategy
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.
